Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
at www.tipranks.com (Fri, 20-Mar 9:30 AM)
Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and Returns
at www.tipranks.com (Fri, 20-Mar 2:01 AM)
Purple Biotech Updates March 2026 Corporate Outlook and Pipeline Milestones
at www.tipranks.com (Thu, 19-Mar 8:42 AM)
